Skip to main content
. 2022 Mar 9;6(7):bvac037. doi: 10.1210/jendso/bvac037

Table 1.

Demographic variables and physical exam findings for participants with and without polycystic ovary syndrome

Untreated PCOS (n = 115) Controls (n = 70) P
Age, y 16 (15-17) 14 (13-16) < .001
Race, n (%) .146
White 98 (85) 46 (73)
Black 15 (13) 15 (23)
Asian 2 (2) 1(2)
> 1 Race 0 1 (2)
Hispanic ethnicity, n (%) 61 (53) 31 (46) .447
BMI 34.3 (30.2-37.8) 30.9 (22.4-36.1) .071
BMI percentile 98.1 (96.0-99.0) 96.7 (67.0-98.6) < .001
Normal BMI (BMI percentile < 90, No. [%]) 13 (11) 18 (26) .024
Menarchea,b 12 (11, 12) 11 (11, 12) .172
Frequency of menses, n (%)c < .001
4-6 wk 3 (3) 34 (92)
1-2 mo 33 (30) 1 (3)
3-6 mo 41 (37) 2 (5)
7-12 mo 22(20) 0
> 1 y 11(10) 0
Hirsutismd FGS 6.0 (3.0-11.0) 0 (0-3.0) < .001
Acne severity, n (%)d < .001
None 8 (7) 18 (50)
Mild 52 (46) 11(31)
Moderate 45 (40) 6 (17)
Severe 8 (7) 1 (2)

Data are expressed as median (25th-75th percentile), mean ± SD, or number (% of total; includes all study controls).

Abbreviations: BMI, body mass index; CGM, continuous glucose monitoring study; FGS, Ferriman-Gallwey score; HIPS, Combined Influence of Puberty and Obesity on Insulin Resistance in Adolescents; MISS, Microbiome Insulin Sensitivity Study; PCOS, polycystic ovary syndrome.

a Missing CGM study values, n = 6.

b Missing HIPS values, n = 12.

c Missing MISS data, n = 17.

d Missing CF study values, HIPS values, and MISS values, n = 35.